Search Tufts Medicine

Displaying 461 - 480 of 491
department
We are compassionate caregivers of patients living with serious illnesses, helping them manage their symptoms, navigate complex care systems and live a good life as long as possible.
Patient Stories
September 27, 2022
Sixty-year-old Mary D. of Winthrop recalls waking up one morning two years ago over the New Year’s holiday and immediately realizing something wasn’t right. “My face felt a little funny,” she says. “I was putting on makeup and couldn’t close my eye correctly. By the end of the day, it was much worse.”
department
The Department of Pathology and Laboratory Medicine provides comprehensive testing and analysis services across all aspects of anatomic and clinical pathology, as well as blood bank analyses. Thousands of specimens land in our labs each day, each sample containing valuable diagnostic information about medical conditions and how to best treat them.
clinical trial
...

This is a clinical study that explores the effects of Tai Chi or Wellness Education on the gut bacteria of patients with Osteoarthritis. Our intervention is aimed at decreasing pain and improving quality of life for osteoarthritis patients.

To measure bacterial changes, participants stool samples will be collected and analyzed.These results will help determine mechanisms between bacteria, pain and behavioral pathways as well as progress future research to the potential disease-modifying role of mind-body approaches.
News
January 18, 2023
Once barely able to walk and given less than six months to live, Linda DaCosta is alive and thriving years later, thanks to her care at Tufts Medical Center.
Articles
October 1, 2020
October is Breast Cancer Awareness Month and Olga Efimova, MD, PhD, a radiologist at MelroseWakefield Imaging, has compiled a list of five important things that every woman should know about mammograms.
clinical trial
...

This study is being conducted in patients with refractory Mycobacterium Avium Complex (MAC), a serious condition which can cause damage to your lung, and is resistant to other treatments. The study is looking at how effective the study drug, Epetraborole in the treatment of refractory MAC. Epetrabole is a oral pill to be taken as 2 tablets one time daily by mouth. Details of study visits are explained below.
clinical trial
...

This trial will help to determine if either the experimental arm (adjuvant reirradiation plus pembrolizumab, followed by pembrolizumab to complete 12 months total of pembrolizumab and/or pembrolizumab alone for 12 months) significantly improves Overall Survival (OS) compared to adjuvant reirradiation plus concurrent platinum chemotherapy in high risk patients.
clinical trial
...

This is a randomized, open-label study of HLX10 plus chemotherapy (Carboplatin-Etoposide) in comparison with Atezolizumab plus chemotherapy in previously untreated US patients with ES-SCLC. Subjects in this study will be randomized to arm A or B at 1:1 ratio as follows: Arm A (HLX10): HLX10 + chemotherapy (carboplatin-etoposide) Arm B (control): Atezolizumab + chemotherapy (carboplatin-etoposide)
clinical trial
...

Recent studies have shown that the causative agent of Lyme disease, the organism (Borrelia burgdorferi), may persist in animals after antibiotic treatment and can be detected by using natural tick vector (Ixodes scapularis) to acquire the organism through feeding (xenodiagnosis). The aim of this study is to investigate the utility of xenodiagnosis for identifying persistence of infection with B. burgdorferi in treated human Lyme disease.
clinical trial
...

This is a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study, with the objective of comparing Progression-Free Survival (PFS) in newly diagnosed GBM patients treated with IGV-001 with patients treated with placebo.
department
The Department of Neurosurgery performs more than 1,700 procedures a year for patients living with high-risk brain tumors, complex spinal cord injuries and disorders presenting from nearly every branch of medicine. Our hands-on approach to patient care is mirrored in our immersive, seven-year residency program, where we prepare tomorrow’s neurosurgeons.
clinical trial
...

The study will evaluate the efficacy, safety and pharmacokinetics of faricimab compared with aflibercept in patients with macular edema due to branch retinal vein occlusion (BRVO) up to the primary endpoint at Week 24.
page
...
Apply for the neurology residency program at Tufts Medicine Tufts Medical Center in Boston and advance your career in neurology by learning from top doctors and surgeons.
clinical trial
...

Our main goal is to use a special type of microscopic imaging to help detect cervical pre-cancers without the need for labels or dyes. We've been working closely with doctors at Tufts Medical Center for more than ten years and have studied images from over seventy cervical tissue samples taken from humans. We shine a laser on the tissues with two different types of light, and this caused certain molecules in the cells to give off light, which we collected and analyzed. By scanning the tissues in this way, we could make 3D images and measure how the cell structures changed with depth.
clinical trial
...

While much has been learned about the acute phase of Coronavirus disease 2019 (COVID-19) in the last year, little is known about the recovery phase. There have recently been several reports in the news and in the medical literature about a prolonged recovery phase after developing acute COVID-19 in some individuals who may have persistent symptoms many months after infection, developing the so called “long COVID”.